DTC Comparative Ads Will Likely Bloom; FDA Studies How To Evaluate New Species
FDA expects to see an increase in direct-to-consumer drug comparison ads after the Agency for Healthcare Research and Quality completes its comparative effectiveness compendium.
You may also be interested in...
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
The agency plans to assess whether the inclusion of disease information in an Rx drug print ad affects consumer perception about the product.